EUVIMEDEUVIMED entdecken
Crossref

Can HALP Score Predict the Prognosis of Patients With Giant Cell Arteritis and Polymyalgia Rheumatica?

Firdevs Ulutaş iD, Hande Şenol, Murat Yiğit, Uğur Karasu, Veli Çobankara

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Firdevs Ulutaş und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Pamukkale University, Denizli, Turkey. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Giant Cell Arteritis, Hemoglobins, Serum Albumin. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The HALP (Hemoglobin, Albumin, Lymphocyte, and Platelet) score has recently gained frequent use in oncology practice as a predictive marker of survival. Giant Cell Arteritis and Polymyalgia Rheumatica are commonly encountered diseases in the elderly population. The present study was designed to evaluate the impact of the HALP score at the time of diagnosis in these patients on the ongoing glucocorticoid (GC) doses during the first year and the mortality rate. Materials and Methods A total of 169 patients who were followed regularly for at least 12 months were included in this retrospective cohort study. The need for additional treatments, and complications (such as infections, malignancies and death) were closely monitored. To investigate the impact of various variables on mortality, we utilized Cox proportional hazards regression models.

Results

Patients in the high‐dose GC group had significantly lower baseline HALP scores (26.17 ± 13.66 vs. 32.62 ± 17.57, p = 0.025) and Prognostic Nutritional Index (PNI) values (47.94 ± 6.22 vs. 50.61 ± 6.49, p = 0.015) compared to the patients who had discontinued GC therapy and/or were maintained on a dose < 5 mg/day at 1 year. The HALP score had a statistically significant predictive value for both the continuation of ≥ 5 mg/day GC therapy at the first year and mortality during the follow‐up. In the multivariate analysis, elevated baseline ESR and the presence of malignancy were independently associated with mortality.

Conclusion

These findings suggest that lower HALP scores may be associated with both prolonged GC dependency and increased risk of death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyalgia RheumaticaGiant Cell ArteritisHemoglobinsSerum AlbuminDecision Support TechniquesLymphocytesHumansRetrospective StudiesFemaleMaleAgedGlucocorticoidsPredictive Value of TestsRisk FactorsBiomarkersTime FactorsAged, 80 and overTreatment OutcomeLymphocyte CountMiddle AgedProportional Hazards ModelsPlatelet CountSerum Albumin, HumanPrognosisKaplan-Meier EstimateNutritional Status

Stichwörter der Autor:innen

HALP scoregiant cell arteritispolymyalgia Romatikaprognostic nutritional index

Substanzen

GlucocorticoidsBiomarkersHemoglobinsSerum AlbuminALB protein, humanSerum Albumin, Human

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Pamukkale University, Denizli, Turkey.
  • Department of Medical Bioistatistics, Pamukkale University, Denizli, Turkey.

ORCID-Profile: Firdevs Ulutaş

Zitieren

APA

Ulutaş, F., Şenol, H., Yiğit, M., Karasu, U., & Çobankara, V. (2025). Can HALP Score Predict the Prognosis of Patients With Giant Cell Arteritis and Polymyalgia Rheumatica?. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70480

Vancouver

Ulutaş F, Şenol H, Yiğit M, Karasu U, Çobankara V. Can HALP Score Predict the Prognosis of Patients With Giant Cell Arteritis and Polymyalgia Rheumatica?. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70480

BibTeX
@article{Uluta2025,
  author = {Ulutaş, Firdevs and Şenol, Hande and Yiğit, Murat and Karasu, Uğur and Çobankara, Veli},
  title = {Can HALP Score Predict the Prognosis of Patients With Giant Cell Arteritis and Polymyalgia Rheumatica?},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70480}
}
Kostenlos starten →